Sign in

CIK 0001635088

  • Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
Operating
EIN
981173944
Phone
+44 12955950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
  1. 4 Planned sale CEO sold 1,983,257 shares at $11.79 ($23,382,600)
  2. 4 Planned sale Chief Accounting Officer sold 250,000 shares at $11.89 ($2,972,500)
  3. 4 Shares withheld for taxes CFO gave up 2,129 shares (to pay taxes)
  4. 4 Shares withheld for taxes President & COO gave up 10,945 shares (to pay taxes)
  5. 4 Other disposition Director disposed of 3,487 shares (other)
  6. 4 Other disposition Director disposed of 3,056 shares (other)
  7. 4 Other disposition Director disposed of 4,245 shares (other)
  8. 4 Other disposition Director disposed of 2,599 shares (other)
  9. 4 Other disposition Director disposed of 894 shares (other)
  10. 4 Grant or award Director acquired 16,406 shares (grant or award)
  11. 4 Grant or award Director acquired 16,406 shares (grant or award)
  12. 4 Grant or award Director acquired 16,406 shares (grant or award)
  13. 4 Grant or award Director acquired 16,406 shares (grant or award)
  14. 4 Grant or award Director acquired 16,406 shares (grant or award)
  15. 4 Grant or award Director acquired 16,406 shares (grant or award)
  16. 4 Shares withheld for taxes CFO gave up 2,341 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Accounting Officer gave up 958 shares (to pay taxes)
  18. 4 Shares withheld for taxes President & COO gave up 10,947 shares (to pay taxes)
  19. 4 Shares withheld for taxes CEO gave up 10,947 shares (to pay taxes)
  20. 4 Grant or award CEO acquired 17,204,821 shares (grant or award)

Page 11 of 26 · 511 filings